“We look forward to expanding our relationship with Accretive Health and working even more closely with its leadership team to implement a single revenue cycle solution and develop a sustainable, long-term platform for our organization,” said Ascension President and CEO Anthony Tersigni.
The renewed partnership marks the culmination of Accretive’s strategic alternatives review process, announced by the company this past July.
“We are confident that we can appropriately scale our model for the significant growth our agreement with Ascension provides,” said Accretive President and CEO Emad Rizk, MD.
Below are three key things to know about the strategic partnership:
1. Ascension will add more than $8 billion in new net patient revenue to Accretive.
2. A newly formed investment vehicle owned by Ascension and TowerBrook Capital Partners plans to invest $200 million in Accretive to support growth initiatives
3. The companies expect the transaction to be completed in the first quarter of 2016.
More articles on finance:
$1B state surplus should pay uncompensated care costs from Health Republic demise
One Medical raises $65M in funding
Cleveland Clinic reaches tentative agreement to close Ohio hospital
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.